Literature DB >> 6620209

The Jenkins activity survey: does it measure psychopathology?

T A Wadden, C H Anderton, G D Foster, W Love.   

Abstract

Previous studies have reached opposite conclusions concerning whether the Jenkins Activity Survey (JAS), a questionnaire measuring the Type A coronary-prone behavior pattern, correlates positively with measures of psychopathology. The present study investigated this question by administering the JAS, the Minnesota Personality Inventory (MMPI) and the State-Trait Anxiety Inventory (STAI) to 85 subjects. No significant correlations were found between the JAS Type A scale and the four MMPI scales measuring neurotic functioning. The Type A scale did correlate significantly with other MMPI scales, but all correlations indicated an inverse relationship between Type A behavior and psychopathology. The Speed and Impatience subscale of the JAS correlated positively with both state and trait anxiety, as found in an earlier study. Results of the present study indicate that the factors assessed by the JAS scales are generally unrelated to factors assessed by traditional measures of psychopathology.

Entities:  

Mesh:

Year:  1983        PMID: 6620209     DOI: 10.1016/0022-3999(83)90055-7

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  3 in total

1.  Central serous chorioretinopathy.

Authors:  J M Jumper
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

2.  Measurement of the Type A behavior pattern in adolescents and young adults: cross-cultural development of AATAB.

Authors:  K Wrzesniewski; D G Forgays; P Bonaiuto
Journal:  J Behav Med       Date:  1990-04

3.  Associations between type A behaviour pattern and psychological distress : 28 years of follow-up of the Oslo Study 1972/1973.

Authors:  Anne Johanne Søgaard; Odd Steffen Dalgard; Ingar Holme; Espen Røysamb; Lise Lund Håheim
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-12-14       Impact factor: 4.328

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.